Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

Facial nerve pathology: emerging strategies for regeneration and functional restoration

Wijekoon S., Zennifer A., Srinivasan SS., Abdulmalik S., Duan B., Kumbar SG.

Narrative Review on Face & Skin, published in J Mater Chem B (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Mater Chem B (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40926668
PMCID
PMC13052384
DOI
10.1039/d5tb01588j

Abstract (original English)

Facial nerve injuries cause significant functional impairments, affect facial expressions, speech, and overall quality of life. This article explores advances in facial nerve regeneration, encompassing both conventional and emerging therapeutic strategies. The regenerative process involves Wallerian degeneration, axonal regrowth, and target muscle reinnervation, where the distal axon degrades and the proximal axon initiates sprouting to restore connectivity. Traditional treatments, including direct nerve repair, autologous grafts, nerve transfers, and rehabilitation, vary in efficacy based on injury severity and timing. Recent innovations in biomaterials, such as collagen scaffolds, synthetic polymers, and graphene-enhanced conduits, provide structural and biochemical support for nerve repair. Electrical stimulation has shown promise in accelerating regeneration by modulating neurotrophic factor expression and guiding axonal growth. Advanced therapies, including stem cell-based interventions, exosome-mediated treatments, and intensive neurorehabilitation, offer new prospects for enhanced recovery. Despite progress, challenges remain in standardizing treatments, ensuring clinical translation, and improving long-term efficacy. This review highlights preclinical models used to assess functional outcomes, discusses bioengineered materials tailored for nerve repair, and explores fut

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Facial NerveAnimalsHumansFacial Nerve InjuriesBiocompatible MaterialsNerve RegenerationTissue Scaffolds

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research